Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

Birt-Hogg-Dubé syndrome (BHDS)

Written2014-01Antonella Maffé, Benedetta Toschi, Maurizio Genuardi
Genetics, Molecular Biology Unit, S Croce e Carle Hospital, Cuneo, Italy (AM); Medical Genetics Laboratory, Santa Chiara Hospital, Pisa (BT); Department of Biomedical, Experimental, Clinical Sciences, University of Florence, Viale Gaetano Pieraccini 6, 50139 Firenze, Italy (MG)
This article is an update of :
2006-02Benedetta Toschi, Maurizio Genuardi
Department of Clinical Pathophysiology, University of Florence, Viale Gaetano Pieraccini 6, 50139 Firenze, Italy

(Note : for Links provided by Atlas : click)


Other namesHornstein-Knickenberg Syndrome
Fibrofolliculomas with Trichodiscomas and Acrochordons
Atlas_Id 10091
Genes implicated inFLCN  
Note Birt-Hogg-Dubé syndrome (BHDS) is characterized by renal oncocytic tumors, benign skin tumors (fibrofolliculomas and trichodiscomas), and spontaneous pneumothorax. The first description of an affected family was provided by Birt, Hogg, and Dubé in 1977.
Inheritance Autosomal Dominant with intrafamilial and interfamilial phenotypic variability. Prevalence is estimated at about 1/200000 although the condition is probably under-diagnosed because of the wide phenotypic variability.


Phenotype and clinics BHDS is a genodermatosis characterized by the triad of benign tumors of the hair follicle, spontaneous pneumothorax and kidney tumors. These manifestations do not have to be simultaneously present in the same individual in order to establish a diagnosis of BHDS, since the phenotype is variable and penetrance is not complete. Other manifestations, such as parotid oncocytomas, parathyroid adenomas, neural tissue tumors, lipomas, angiolipomas, colorectal adenomas, and connective tissue abnormalities, have been occasionally observed but their association with the syndrome is not yet proven.
Cutaneous tumors are fibrofolliculomas, trichodiscomas and/or acrochordons. Fibrofolliculomas and trichodiscomas tend to appear in the third or fourth decade of life as small white or skin-colored multiple papules on the face, neck and upper trunk. Acrochordon is a non specific designation for small and soft skin tags.
Almost all BHDS patients have lung cysts (80%-100%), and one-fifth develop spontaneous pneumothorax. Typically there are multiple, irregularly-shaped, thin-walled pulmonary cysts of various sizes, predominantly distributed in the lower medial and subpleural regions of the lung. Pathological characteristics indicate that the BHDS lung cyst is a hamartoma-like lesion associated with deranged mTOR signaling.
The presence of spontaneous pneumothorax in a member of a BHDS family could be used as a criterion for the diagnosis of BHDS due to its strong association with BHDS.
  Multiple trichodiscomas of the neck.
Differential diagnosis BHDS manifestations occur in other diseases. These include renal cancer syndromes, namely von Hippel-Lindau disease, hereditary leiomyomatosis/renal cell cancer, hereditary papillary renal cancer, hereditary clear cell renal cell cancer, tuberous sclerosis complex, familial paraganglioma syndrome, and familial oncocytoma.
Tuberous sclerosis, Cowden syndrome and Brooke-Spiegler syndrome are characterized by cutaneous manifestations that can present similaraties with BHDS lesions. However, the cutaneous hamartomas in these conditions are angiofibromas, trichilemmomas and trichoepitheliomas, respectively.
BHDS should also be differentiated from syndromes associated with cystic lung disease and pneumothorax. Lymphangioleiomyomatosis and pulmonary endometriosis should be considered in women of reproductive age.
Neoplastic risk Approximately 27% of BHDS patients develop renal tumors of different histological type:
- chromophobe (34%),
- hybrid chromophobe/oncocytic (50%),
- oncocytoma (5%), and
- clear cell renal carcinoma (9%).
Hybrid tumors are most characteristic of this condition, and several lesions initially diagnosed as oncocytomas or chromofobe tumors have been defined as hybrid tumors upon reappraisal. Multiple histological types of kidney tumors can be found in the same BHDS family, in the same patient or even in the same kidney.
BHDS patients with bilateral renal masses and oncocytoma/oncocytic neoplasm on one side have significantly lower histological concordance rates in the contralateral kidney compared to non-BHDS patients; this underscores the need for careful periodic surveillance, to detect lesions with a higher malignant potential.
Treatment - No specific medical treatment exists for the cutaneous lesions of BHDS. Surgical removal has provided definitive treatment of solitary perifollicular fibromas and electrodesiccation may be helpful in removal of multiple lesions, which, however, can recur.
- High-resolution CT scan should be performed to identify lung cysts. Patients should be educated about the risk of pneumothorax.
- Individuals at risk or affected by BHDS should be radiographically screened for renal tumors at periodic intervals and they are best treated with nephron sparing surgical approaches.
- Colonoscopy should be considered, although there is as yet no evidence that the risk of colorectal tumors is increased in BHDS.
FLCN loss has been shown to result in upregulation of the AKT-mTOR pathway both in vitro and in a conditional Flcn mouse knockout model. These results suggest that mTOR inhibitors such as rapamycin analogues (i.e. sirolimus) might be useful potential therapeutic agents for BHDS-associated renal tumors.
Prognosis Prognosis depends on the number, type and age at diagnosis of kidney tumors. Hybrid and chromophobe tumors have malignant potential, while pure renal oncocytomas are benign. Mean age at diagnosis of kidney tumors is 50.7 years.

Genes involved and Proteins

Gene NameFLCN (folliculin gene)
Location 17p11.2
Note Genomic coordinates (GRCh37): 17: 17115522 - 17140501.
Description Total gene size: 24971 bp.
Transcription Alternative splicing results in two transcript variants encoding different isoforms. mRNA is expressed in a variety of tissues, including the skin, the kidney, the lung, the pancreas, parotid gland, and the brain. Tissues with reduced expression of FLCN mRNA include heart, muscle and liver. FLCN mRNA is not expressed in renal tumors from BHDS patients.
Note Folliculin
Description The protein contains a conserved SLS potential phosphorylation site, a glutamic acid-rich coiled-coil domain, an N-glycosylation site, and 3 myristoylation sites.
Function FLCN function is not yet completely understood. It binds to FNIP1 and FNIP2 (via its C-terminus) and colocalizes with them in the cytoplasm. However, unbound FLCN is mainly localized in the nucleus. FLCN-FNP1 and FLCN-FNP2 complexes interact with AMPK and seem to modulate mTOR activity with opposite effects in a context-dependent manner. FLCN is phosphorylated by AMPK and mTOR, and phosphorylation is enhanced by binding with FNIP1 and FNIP2.
FLCN has also a role in the regulation of key TGF-beta signalling. Its inactivation leads to activation of the transcription factor TFE3 and to overexpression of nuclear genes involved in the transcription and replication of the mitochondrial genome.
Structure: The crystal structure of folliculin carboxy-terminal domain suggests that it is distantly related to Differentially Expressed in Normal cells and Neoplasia (DENN) domain proteins, that serve as guanine exchange factors (GEFs) for Rab GTPases. In particular, folliculin displays GEF activity towards Rab35, facilitating its role in vesicle membrane transport.
Note Frameshift insertions or deletions within a mononucleotide repeat tract containing 8 cytosines within exon 11 are the most frequent FLCN constitutional mutations, detected in approximately 50% of BHDS families. The spectrum of additional mutations is heterogeneous. Overall, FLCN point mutations are found in 60%-88% of BHDS cases, depending on selection criteria. Large FLCN intragenic deletions and duplications may account for approximately 5% of BHDS cases. The tract including the 5' UTR and exon 1 seems to be a hot-spot for large deletions.
Animal Models: Hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis is a naturally occurring canine kidney cancer syndrome that was originally described in German shepherd dogs, and is caused by canine Bhd gene mutations.
In a colony of Sprague-Dawley rats in Japan, designated the 'Nihon' rat, a germline frameshift mutation in the Bhd gene resulting in a premature stop codon was found to be associated with hereditary renal carcinoma. The homozygous mutant condition was lethal at an early stage of foetal life in the rat.
Other rat or mouse BHDS models were generated deleting FLCN homologues: targeted homozygous deletion of Bhd in rat and mice was embryonic lethal whereas heterozygous animals manifested hyperproliferative diseases of various organs including preneoplastic kidney lesions and kidney tumors.
Deletion of the FLCN homologue in Drosophila causes growth delay. In this model, growth can be rescued by dietary changes, suggesting that modulation of the local nutrient conditions might be a potential treatment for BHDS lesions.


Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys.
Baba M, Furihata M, Hong SB, Tessarollo L, Haines DC, Southon E, Patel V, Igarashi P, Alvord WG, Leighty R, Yao M, Bernardo M, Ileva L, Choyke P, Warren MB, Zbar B, Linehan WM, Schmidt LS.
J Natl Cancer Inst. 2008 Jan 16;100(2):140-54. doi: 10.1093/jnci/djm288. Epub 2008 Jan 8.
PMID 18182616
Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.
Baba M, Hong SB, Sharma N, Warren MB, Nickerson ML, Iwamatsu A, Esposito D, Gillette WK, Hopkins RF 3rd, Hartley JL, Furihata M, Oishi S, Zhen W, Burke TR Jr, Linehan WM, Schmidt LS, Zbar B.
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15552-7. Epub 2006 Oct 6.
PMID 17028174
Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dube syndrome.
Benhammou JN, Vocke CD, Santani A, Schmidt LS, Baba M, Seyama K, Wu X, Korolevich S, Nathanson KL, Stolle CA, Linehan WM.
Genes Chromosomes Cancer. 2011 Jun;50(6):466-77. doi: 10.1002/gcc.20872. Epub 2011 Mar 15.
PMID 21412933
Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons.
Birt AR, Hogg GR, Dube WJ.
Arch Dermatol. 1977 Dec;113(12):1674-7.
PMID 596896
The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma.
Boris RS, Benhammou J, Merino M, Pinto PA, Linehan WM, Bratslavsky G.
J Urol. 2011 Jun;185(6):2050-5. doi: 10.1016/j.juro.2011.02.051. Epub 2011 Apr 15.
PMID 21496834
Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma.
Choueiri TK, Plantade A, Elson P, Negrier S, Ravaud A, Oudard S, Zhou M, Rini BI, Bukowski RM, Escudier B.
J Clin Oncol. 2008 Jan 1;26(1):127-31. doi: 10.1200/JCO.2007.13.3223.
PMID 18165647
Multiple lipomas, angiolipomas, and parathyroid adenomas in a patient with Birt-Hogg-Dube syndrome.
Chung JY, Ramos-Caro FA, Beers B, Ford MJ, Flowers F.
Int J Dermatol. 1996 May;35(5):365-7.
PMID 8734663
Multiple fibrofolliculomas with trichodiscomas and acrochordons.
Fujita WH, Barr RJ, Headley JL.
Arch Dermatol. 1981 Jan;117(1):32-5.
PMID 7458379
Pulmonary cysts of Birt-Hogg-Dube syndrome: a clinicopathologic and immunohistochemical study of 9 families.
Furuya M, Tanaka R, Koga S, Yatabe Y, Gotoda H, Takagi S, Hsu YH, Fujii T, Okada A, Kuroda N, Moritani S, Mizuno H, Nagashima Y, Nagahama K, Hiroshima K, Yoshino I, Nomura F, Aoki I, Nakatani Y.
Am J Surg Pathol. 2012 Apr;36(4):589-600. doi: 10.1097/PAS.0b013e3182475240.
PMID 22441547
Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.
Hasumi H, Baba M, Hasumi Y, Huang Y, Oh H, Hughes RM, Klein ME, Takikita S, Nagashima K, Schmidt LS, Linehan WM.
J Natl Cancer Inst. 2012 Nov 21;104(22):1750-64. doi: 10.1093/jnci/djs418. Epub 2012 Nov 12.
PMID 23150719
Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling.
Hong SB, Oh H, Valera VA, Stull J, Ngo DT, Baba M, Merino MJ, Linehan WM, Schmidt LS.
Mol Cancer. 2010b Jun 23;9:160. doi: 10.1186/1476-4598-9-160.
PMID 20573232
Birt-Hogg-Dube syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2.
Khoo SK, Bradley M, Wong FK, Hedblad MA, Nordenskjold M, Teh BT.
Oncogene. 2001 Aug 23;20(37):5239-42.
PMID 11526515
Clinical and genetic studies of Birt-Hogg-Dube syndrome.
Khoo SK, Giraud S, Kahnoski K, Chen J, Motorna O, Nickolov R, Binet O, Lambert D, Friedel J, Levy R, Ferlicot S, Wolkenstein P, Hammel P, Bergerheim U, Hedblad MA, Bradley M, Teh BT, Nordenskjold M, Richard S.
J Med Genet. 2002 Dec;39(12):906-12.
PMID 12471204
Birt-Hogg-Dube renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.
Klomp JA, Petillo D, Niemi NM, Dykema KJ, Chen J, Yang XJ, Saaf A, Zickert P, Aly M, Bergerheim U, Nordenskjold M, Gad S, Giraud S, Denoux Y, Yonneau L, Mejean A, Vasiliu V, Richard S, MacKeigan JP, Teh BT, Furge KA.
BMC Med Genomics. 2010 Dec 16;3:59. doi: 10.1186/1755-8794-3-59.
PMID 21162720
The Heidelberg classification of renal cell tumours.
Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Storkel S, van den Berg E, Zbar B.
J Pathol. 1997 Oct;183(2):131-3. (REVIEW)
PMID 9390023
[Multiple trichodiscomas associated with colonic polyposis].
Le Guyadec T, Dufau JP, Poulain JF, Vaylet F, Grossin M, Lanternier G.
Ann Dermatol Venereol. 1998 Oct;125(10):717-9.
PMID 9835964
A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog.
Lingaas F, Comstock KE, Kirkness EF, Sorensen A, Aarskaug T, Hitte C, Nickerson ML, Moe L, Schmidt LS, Thomas R, Breen M, Galibert F, Zbar B, Ostrander EA.
Hum Mol Genet. 2003 Dec 1;12(23):3043-53. Epub 2003 Oct 7.
PMID 14532326
Parotid oncocytoma in the Birt-Hogg-Dube syndrome.
Liu V, Kwan T, Page EH.
J Am Acad Dermatol. 2000 Dec;43(6):1120-2.
PMID 11100034
Genetic characterization of the Drosophila birt-hogg-dube syndrome gene.
Liu W, Chen Z, Ma Y, Wu X, Jin Y, Hou S.
PLoS One. 2013 Jun 17;8(6):e65869. doi: 10.1371/journal.pone.0065869. Print 2013.
PMID 23799055
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome.
Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, Duray P, Merino M, Choyke P, Pavlovich CP, Sharma N, Walther M, Munroe D, Hill R, Maher E, Greenberg C, Lerman MI, Linehan WM, Zbar B, Schmidt LS.
Cancer Cell. 2002 Aug;2(2):157-64.
PMID 12204536
Crystal structure of folliculin reveals a hidDENN function in genetically inherited renal cancer.
Nookala RK, Langemeyer L, Pacitto A, Ochoa-Montano B, Donaldson JC, Blaszczyk BK, Chirgadze DY, Barr FA, Bazan JF, Blundell TL.
Open Biol. 2012 Aug;2(8):120071. doi: 10.1098/rsob.120071.
PMID 22977732
A germ-line insertion in the Birt-Hogg-Dube (BHD) gene gives rise to the Nihon rat model of inherited renal cancer.
Okimoto K, Sakurai J, Kobayashi T, Mitani H, Hirayama Y, Nickerson ML, Warren MB, Zbar B, Schmidt LS, Hino O.
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2023-7. Epub 2004 Feb 9.
PMID 14769940
Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome.
Pavlovich CP, Grubb RL 3rd, Hurley K, Glenn GM, Toro J, Schmidt LS, Torres-Cabala C, Merino MJ, Zbar B, Choyke P, Walther MM, Linehan WM.
J Urol. 2005 May;173(5):1482-6.
PMID 15821464
Fibrofolliculomas, tricodiscomas and acrochordons (Birt-Hogg-Dube) associated with intestinal polyposis.
Rongioletti F, Hazini R, Gianotti G, Rebora A.
Clin Exp Dermatol. 1989 Jan;14(1):72-4.
PMID 2805394
Bilateral renal cell carcinoma in the Birt-Hogg-Dube syndrome.
Roth JS, Rabinowitz AD, Benson M, Grossman ME.
J Am Acad Dermatol. 1993 Dec;29(6):1055-6.
PMID 8245249
Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome.
Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM.
Am J Hum Genet. 2005 Jun;76(6):1023-33. Epub 2005 Apr 25.
PMID 15852235
Familial multiple desmoplastic trichoepitheliomas.
Shapiro PE, Kopf AW.
Arch Dermatol. 1991 Jan;127(1):83-7.
PMID 1986711
Familial multiple trichodiscomas. A clinicopathologic study.
Starink TM, Kisch LS, Meijer CJ.
Arch Dermatol. 1985 Jul;121(7):888-91.
PMID 4015134
Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL/Fnip2) protein.
Takagi Y, Kobayashi T, Shiono M, Wang L, Piao X, Sun G, Zhang D, Abe M, Hagiwara Y, Takahashi K, Hino O.
Oncogene. 2008 Sep 11;27(40):5339-47. doi: 10.1038/onc.2008.261. Epub 2008 Jul 28.
PMID 18663353
Characteristics of pulmonary cysts in Birt-Hogg-Dube syndrome: thin-section CT findings of the chest in 12 patients.
Tobino K, Gunji Y, Kurihara M, Kunogi M, Koike K, Tomiyama N, Johkoh T, Kodama Y, Iwakami S, Kikkawa M, Takahashi K, Seyama K.
Eur J Radiol. 2011 Mar;77(3):403-9. doi: 10.1016/j.ejrad.2009.09.004. Epub 2009 Sep 25.
PMID 19782489
Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia.
Toro JR, Glenn G, Duray P, Darling T, Weirich G, Zbar B, Linehan M, Turner ML.
Arch Dermatol. 1999 Oct;135(10):1195-202.
PMID 10522666
Fibrofolliculomas, trichodiscomas, and acrochordons: the Birt-Hogg-Dube syndrome.
Ubogy-Rainey Z, James WD, Lupton GP, Rodman OG.
J Am Acad Dermatol. 1987 Feb;16(2 Pt 2):452-7.
PMID 3819093
Birt-Hogg-Dube syndrome: two patients with neural tissue tumors.
Vincent A, Farley M, Chan E, James WD.
J Am Acad Dermatol. 2003 Oct;49(4):717-9.
PMID 14512924
Expression of Birt-Hogg-Dube gene mRNA in normal and neoplastic human tissues.
Warren MB, Torres-Cabala CA, Turner ML, Merino MJ, Matrosova VY, Nickerson ML, Ma W, Linehan WM, Zbar B, Schmidt LS.
Mod Pathol. 2004 Aug;17(8):998-1011.
PMID 15143337
Multiple fibrofolliculomas (Birt-Hogg-Dube) associated with a large connective tissue nevus.
Weintraub R, Pinkus H.
J Cutan Pathol. 1977 Dec;4(6):289-99.
PMID 753849
Familial renal oncocytoma: clinicopathological study of 5 families.
Weirich G, Glenn G, Junker K, Merino M, Storkel S, Lubensky I, Choyke P, Pack S, Amin M, Walther MM, Linehan WM, Zbar B.
J Urol. 1998 Aug;160(2):335-40.
PMID 9679872
Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome.
Zbar B, Alvord WG, Glenn G, Turner M, Pavlovich CP, Schmidt L, Walther M, Choyke P, Weirich G, Hewitt SM, Duray P, Gabril F, Greenberg C, Merino MJ, Toro J, Linehan WM.
Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):393-400.
PMID 11927500


This paper should be referenced as such :
Maff_, A ; Toschi, B ; Genuardi, M
Birt-Hogg-Dubé syndrome (BHDS)
Atlas Genet Cytogenet Oncol Haematol. 2014;18(7):521-525.
Free journal version : [ pdf ]   [ DOI ]
On line version :
History of this paper:
Toschi, B ; Genuardi, M. Birt-Hogg-Dube Syndrome (BHD). Atlas Genet Cytogenet Oncol Haematol. 2006;10(3):203-205.

Other genes implicated (Data extracted from papers in the Atlas) [ 2 ]


REVIEW articlesautomatic search in PubMed
Last year articlesautomatic search in PubMed

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Mon Dec 14 18:29:39 CET 2020

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us